跳至主要内容
临床试验/NCT01483443
NCT01483443已完成3 期

Prophylactic Oophorectomy Followed by Chemotherapy Versus Chemotherapy Alone in Colorectal Patients With or Without Ovarian Metastasis

Gachon University Gil Medical Center2 个研究点 分布在 2 个国家目标入组 140 人开始时间: 2008年8月最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
140
试验地点
2
主要终点
Overall survival

研究概览

简要总结

This is a prospective phase III trial to define the role of oophorectomy in metastatic colorectal cancer patients with ovarian metastasis.

详细描述

A recent study demonstrated that colorectal cancer with ovarian metastases were less responsive to chemotherapy compared to extraovarian metastases. The survival impact of oophorectomy has not been defined yet in this clinical setting. The incidence of microscopic ovarian metastasis has been reported to be approximately 10%. Therefore, the investigators propose a prospective study of oophorectomy followed by standard chemotherapy versus standard chemotherapy alone to determine whether oophorectomy increases survival.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
55 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • histologically confirmed adenocarcinoma of colon
  • documented ovarian metastasis in CT or MRI or PET-CT
  • advanced (stage IV), metastatic, or recurrent
  • ECOG performance status of 0~2
  • adequate marrow, hepatic, renal and cardiac functions
  • no prior surgical treatment to ovary
  • provision of a signed written informed consent

排除标准

  • patient who refuses oophorectomy
  • medical condition in which surgery cannot be tolerated Any waiver of these inclusion and exclusion criteria must be approved by the investigator on a case-by case basis prior to enrolling the subject. This must be documented by the investigator. No subject will be allowed to enroll in this study more than once.

研究组 & 干预措施

Oophrectomy group

Experimental

Patient undergone oophrectomy along with primary tumor

干预措施: Oophrectomy (Procedure)

without oophrectomy

No Intervention

Patient group without oophrectomy

结局指标

主要结局

Overall survival

时间窗: 3 years

次要结局

  • Disease free survival(3 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Won-Suk Lee

Assistant Prof

Gachon University Gil Medical Center

研究点 (2)

Loading locations...

相似试验

Oophorectomy Followed by Chemotherapy Versus... | 临床试验